Innovative Bioresearch Ltd Company Profile
Innovative Bioresearch Ltd is a forward-thinking technology company built on a foundation of technical excellence and transparency. The firm operates at the unique intersection of decentralized science (DeSci) and high-performance gaming. Having pioneered the DeSci movement with the launch of the INNBC token, the company has successfully created a decentralized ecosystem aimed at supporting medical research and innovation. Innovative Bioresearch distinguishes itself by focusing exclusively on the delivery of tangible products rather than financial promises. This commitment to real-world utility is clearly demonstrated in its gaming division, where the company develops advanced software such as "INNBC STARFIGHTER," released on Steam. By utilizing a proprietary engine optimized for extreme performance—reaching a stable 144 FPS—the company bridges the gap between the nostalgic coin-op arcade culture of the past and the cutting-edge technical standards of the present. Furthermore, with its scientific publications cited by institutions such as Harvard University, Innovative Bioresearch continues to prove that complex technological ecosystems, from blockchain integration to custom-built game engines, can coexist to provide stable, functional, and high-quality experiences for a global audience.
Company Founder
Jonathan Fior
Owner and CEO
Jonathan Fior was born in Los Angeles, USA, in 1982 to Italian parents. After moving to Italy as a child, he pursued his education there, graduating with a bachelor's degree in medical biotechnology from the University of Milan—a country renowned for its academic excellence. Passionate about both medical science and computer science, he also gained hands-on experience as a software developer, building apps and games.
After graduation, Jonathan dove into HIV research with a mission to innovate in the field. He conceived the use of irradiated SupT1 cells as decoy targets to prevent CD4+ T cell depletion and reduce HIV cytotoxicity. He first validated this concept in vitro studies, proposing SupT1 cell infusion as a potential cell-based therapy for HIV. To advance it to in vivo testing, he founded Innovative Bioresearch in 2014. He then led a pioneering pilot study of SupT1 cell infusion in humanized mice [1].
Recognizing blockchain's potential to transform pharma, Jonathan became a trailblazer in decentralized science (DeSci) by issuing INNBC (InnovativeBioresearchCoin) in 2018—widely regarded as the original DeSci token. He also authored a highly regarded comprehensive review on salamander regeneration, its differences from human healing, and its promise as a model for novel regenerative and anticancer therapies [2].
Most recently, he published the first peer-reviewed DeSci study [3] (on the Springer-Nature network) demonstrating the real-world application of the INNBC DApp for secure, permanent blockchain-based biomedical data storage and sharing—a work cited by Harvard University.
Building on his software development background, Innovative Bioresearch is now expanding into game development through INNBC Gaming. This includes titles like INNBC Starfighter (a high-res, 60+ FPS bullet-hell shooter evoking 90s arcade classics), available on Steam—further blending blockchain, innovation, and entertainment.